logo
logo
Products 

Purpose of Italy Peptide Receptor Radionuclide Therapy

avatar
Ben Wood
collect
0
collect
0
collect
0
Purpose of Italy Peptide Receptor Radionuclide Therapy

Peptide receptor radionuclide therapy (PRRT) can be also considered as a personalized cancer therapy, as radio peptide can be altered into the unique biologic characteristics of the patient and the molecular properties of the tumor.


Peptide receptor radionuclide therapy (PRRT) is utilised in neuroendocrine tumours that express type 2 somatostatin receptors (sst2). The goal of this multi-cycle prospective phase I-II trial was to assess the toxicity and efficacy of 177Lu-DOTATATE.


Read More:

https://medium.com/@dataguy.cmi/italy-peptide-receptor-radionuclide-therapy-prrt-used-to-treat-cancer-associated-with-315916bc0cfb


Click here for Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Report:

https://www.coherentmarketinsights.com/market-insight/italy-peptide-receptor-radionuclide-therapy-market-3139


Click here for Italy Peptide Receptor Radionuclide Therapy (PRRT) Market Press Release:

https://www.coherentmarketinsights.com/press-release/italy-peptide-receptor-radionuclide-therapy-prrt-market-to-surpass-us-72-million-by-2027-2541

collect
0
collect
0
collect
0
avatar
Ben Wood